Understanding the nuances behind why a physician makes a decision regarding an information source when making a clinical decision is key to learning the best way to deliver content that will prompt an engagement.
Generic drugmaker Mylan NV said its manufacturing partner for EpiPen devices had expanded a recall of the life-saving allergy shot in the United States and other markets.
Kaspar the social robot has helped around 170 autistic children in a handful of schools and hospitals over the last 10 years. But with approximately 700,000 people in Britain on the autism spectrum, according to the National Autistic Society, the university wants Kaspar to help more people.
Napo Pharmaceuticals Inc. – a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas – and Jaguar Animal Health Inc. – an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals and high value horses – announced today that they have entered into a definitive merger agreement by unanimous approval by the boards of directors of both companies.
The U.S. FDA granted full approval for Tagrisso (osimertinib) 80-mg once-daily tablets for treating metastatic EGFR T790M mutation-positive NSCLC.
Vencerx Therapeutics announced that Robert Ring will join the company as chief executive officer and Jeffrey Stevenson will join as chairman of the board.
GV has invested in a company called SpyBiotech, which focuses on a so-called “super glue” that combines two parts of the bacteria that causes strep throat.
As biologic medications administered through prefilled syringes continue to supplement and enter new therapeutic areas, more and more patients will need to embark on a learning curve that is possibly unlike any they have experienced prior.
Seattle Genetics announced that Karen Walker will be joining the company as vice president of Global Quality in mid-April 2017. She was formerly vice president Global Head Cell and Gene Therapies Technical Development and Manufacturing at Novartis.